TrialClinical drug investigation2017

Effect of Degarelix, a Gonadotropin-Releasing Hormone Receptor Antagonist for the Treatment of Prostate Cancer, on Cardiac Repolarisation in a Randomised, Placebo and Active Comparator Controlled Thorough QT/QTc Trial in Healthy Men.

Håkan Olsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.